Cargando…
Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families
The present investigation extends our immunochemical characterization of binding site heterogeneity among a large series of monoclonal anti- phosphocholine (PC) antibodies. Hybridoma proteins (HP) from eight genetically distinct strains are included in this study, yet no strain specific characterist...
Formato: | Texto |
---|---|
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
1981
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186518/ https://www.ncbi.nlm.nih.gov/pubmed/7299349 |
_version_ | 1782145960265121792 |
---|---|
collection | PubMed |
description | The present investigation extends our immunochemical characterization of binding site heterogeneity among a large series of monoclonal anti- phosphocholine (PC) antibodies. Hybridoma proteins (HP) from eight genetically distinct strains are included in this study, yet no strain specific characteristics are observed. These HP, as previously shown (5), are divided into three well-defined families based on public or family-specific Id and L chain isotypes characteristic of three PC- binding myeloma proteins: T15, M603, and M511. All antibodies exhibited some degree of inter- or intra-family heterogeneity, or both. Some of this intra-family diversity was reflected by differential reactivity for PC when attached to three different carriers. In spite of this, the specificity profiles for hapten analogues of PC, as measured by hapten inhibition of binding, were the same for all members of the T15 family. Altering the carrier had no effect, thus suggesting that the binding site pocket for PC is essentially preserved, whereas that for carrier is variable. Similar conclusions were reached for most of the M603 HP, although the binding site is different from the T15 HP. The M511 HP stand in sharp contrast to the HP in the other two families because their binding sites exhibit extensive variability. The independence in reactivity for PC and PC plus carrier offers a rational explanation for idiotypic and/or structural heterogeneity within a family. More importantly it suggests interesting strategies for diversification within one group of antibodies. |
format | Text |
id | pubmed-2186518 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 1981 |
publisher | The Rockefeller University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-21865182008-04-17 Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families J Exp Med Articles The present investigation extends our immunochemical characterization of binding site heterogeneity among a large series of monoclonal anti- phosphocholine (PC) antibodies. Hybridoma proteins (HP) from eight genetically distinct strains are included in this study, yet no strain specific characteristics are observed. These HP, as previously shown (5), are divided into three well-defined families based on public or family-specific Id and L chain isotypes characteristic of three PC- binding myeloma proteins: T15, M603, and M511. All antibodies exhibited some degree of inter- or intra-family heterogeneity, or both. Some of this intra-family diversity was reflected by differential reactivity for PC when attached to three different carriers. In spite of this, the specificity profiles for hapten analogues of PC, as measured by hapten inhibition of binding, were the same for all members of the T15 family. Altering the carrier had no effect, thus suggesting that the binding site pocket for PC is essentially preserved, whereas that for carrier is variable. Similar conclusions were reached for most of the M603 HP, although the binding site is different from the T15 HP. The M511 HP stand in sharp contrast to the HP in the other two families because their binding sites exhibit extensive variability. The independence in reactivity for PC and PC plus carrier offers a rational explanation for idiotypic and/or structural heterogeneity within a family. More importantly it suggests interesting strategies for diversification within one group of antibodies. The Rockefeller University Press 1981-11-01 /pmc/articles/PMC2186518/ /pubmed/7299349 Text en This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.rupress.org/terms). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 4.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/4.0/). |
spellingShingle | Articles Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title | Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title_full | Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title_fullStr | Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title_full_unstemmed | Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title_short | Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families |
title_sort | anti-phosphocholine hybridoma antibodies. ii. functional analysis of binding sites within three antibody families |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2186518/ https://www.ncbi.nlm.nih.gov/pubmed/7299349 |